رجوع
نطاق اليوم
KWD 114.77
KWD 116.47
نطاق 52 أسبوعًا
KWD 73.31
KWD 125.14
حجم التداول
6,391,503
متوسط 50 يوم / 200 يوم
KWD 115.65
/
KWD 94.64
الإغلاق السابق
KWD 114.18
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 15.7 | 0.4 |
| P/B | 5.4 | 2.9 |
| ROE % | 36.9 | 3.8 |
| Net Margin % | 28.1 | 3.9 |
| Rev Growth 5Y % | 7.5 | 10.0 |
| D/E | 1.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 128.540
+11.1%
Low: KWD 100.000
High: KWD 150.000
مكرر الربحية المستقبلي
22.6
ربحية السهم المستقبلية
KWD 5.124
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
67 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 10.156
KWD 9.873 – KWD 10.374
|
74 B | 5 |
| FY2029 |
KWD 10.360
KWD 10.070 – KWD 10.582
|
75 B | 2 |
| FY2028 |
KWD 10.768
KWD 8.850 – KWD 13.125
|
75 B | 7 |
النقاط الرئيسية
Revenue grew 7.49% annually over 5 years — modest growth
ROE of 36.91% indicates high profitability
Net margin of 28.08% shows strong profitability
Generating 12.36B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.18%
Capital efficient — spends only 6.33% of revenue on capex
النمو
Revenue Growth (5Y)
7.49%
Revenue (1Y)1.31%
Earnings (1Y)6.64%
FCF Growth (3Y)16.27%
الجودة
Return on Equity
36.91%
ROIC19.47%
Net Margin28.08%
Op. Margin41.19%
الأمان
Debt / Equity
0.96
Current Ratio1.54
Interest Coverage0.00
التقييم
P/E Ratio
15.67
P/B Ratio5.44
EV/EBITDA12.02
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.31% | Revenue Growth (3Y) | 3.99% |
| Earnings Growth (1Y) | 6.64% | Earnings Growth (3Y) | 607.18% |
| Revenue Growth (5Y) | 7.49% | Earnings Growth (5Y) | 8.75% |
| Profitability | |||
| Revenue (TTM) | 65.01B | Net Income (TTM) | 18.25B |
| ROE | 36.91% | ROA | 13.34% |
| Gross Margin | 81.50% | Operating Margin | 41.19% |
| Net Margin | 28.08% | Free Cash Flow (TTM) | 12.36B |
| ROIC | 19.47% | FCF Growth (3Y) | 16.27% |
| Safety | |||
| Debt / Equity | 0.96 | Current Ratio | 1.54 |
| Interest Coverage | 0.00 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 15.67 | P/B Ratio | 5.44 |
| P/S Ratio | 4.40 | PEG Ratio | 1.88 |
| EV/EBITDA | 12.02 | Dividend Yield | 0.03% |
| Market Cap | 285.98B | Enterprise Value | 321.95B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 65.01B | 64.17B | 60.12B | 59.28B | 48.70B |
| Net Income | 18.25B | 17.12B | 365.00M | 14.52B | 13.05B |
| EPS (Diluted) | 7.28 | 6.74 | 0.14 | 5.71 | 5.14 |
| Gross Profit | 52.98B | 48.98B | 43.99B | 41.87B | 35.08B |
| Operating Income | 26.78B | 20.22B | 2.95B | 18.28B | 13.20B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 136.87B | 117.11B | 106.68B | 109.16B | 105.69B |
| Total Liabilities | 84.20B | 70.73B | 69.04B | 63.10B | 67.44B |
| Shareholders' Equity | 52.61B | 46.31B | 37.58B | 45.99B | 38.18B |
| Total Debt | 50.53B | 38.27B | 36.27B | 31.99B | 34.63B |
| Cash & Equivalents | 14.57B | 13.24B | 6.84B | 12.69B | 8.10B |
| Current Assets | 43.52B | 38.78B | 32.17B | 35.72B | 30.27B |
| Current Liabilities | 28.33B | 28.42B | 25.69B | 24.24B | 23.87B |